Pulmonary toxicity: side effects on the lungs.
This is a real world study of Pulmonary toxicity among people who take Bendamustine, Rituxan. The study is created by eHealthMe based on 4 reports from FDA and social media.
What are the drugs
Bendamustine (latest outcomes) has active ingredients of bendamustine hydrochloride. It is often used in lymphoplasmacytoid lymphoma/immunocytoma.
Rituxan (latest outcomes from 10,314 users) has active ingredients of rituximab. It is often used in rheumatoid arthritis.
On Feb, 26, 2015: 4 people reported to have Pulmonary Toxicity when taking Bendamustine, Rituxan are studied.
Gender of people who have Pulmonary toxicity when taking the drugs * :
|Pulmonary toxicity||67%||33% |
Age of people who have Pulmonary toxicity when taking the drugs * :
|Pulmonary toxicity||0%||0%||0%||0%||0%||0%||100%||0% |
Severity of Pulmonary toxicity when taking the drugs ** :
How people recovered from Pulmonary toxicity ** :
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
More about the drug combination: Bendamustine, Rituxan drug interactions
You can also:
NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.